Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it...

Peregrine Pharmaceuticals (PPHM +1.9%) reverses earlier losses after announcing late Friday it had entered into an At Market Issuance Sales Agreement with MLV & Co. to sell up to $75M in stock. The biotech firm also said it issued options to purchase 200K shares each to CEO Steven King and CFO Paul Lytle under the company's stock incentive plan.